Thermo Fisher Scientific Proceeds from Cross-Currency Swap Interest Settlements increased by 92.0% to $96.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 10.3%, from $87.00M to $96.00M. Over 4 years (FY 2021 to FY 2025), Proceeds from Cross-Currency Swap Interest Settlements shows an upward trend with a 140.6% CAGR.
Fluctuations reflect changes in interest rate differentials and currency hedging strategies rather than core operational performance.
This represents cash inflows derived from the interest settlement component of cross-currency interest rate swaps used t...
Specific to companies with significant international debt structures; peers may report this within broader hedging or financing line items.
tmo_proceeds_from_cross_currency_swap_settlements| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.00M | $2.00M | $2.00M | $3.75M | $3.75M | $3.75M | $3.75M | $2.00M | $33.00M | $1.00M | $34.00M | $64.00M | $47.00M | $92.00M | $49.00M | $87.00M | $47.00M | $84.00M | $50.00M | $96.00M |
| QoQ Change | — | +0.0% | +0.0% | +87.5% | +0.0% | +0.0% | +0.0% | -46.7% | >999% | -97.0% | >999% | +88.2% | -26.6% | +95.7% | -46.7% | +77.6% | -46.0% | +78.7% | -40.5% | +92.0% |
| YoY Change | — | — | — | — | +87.5% | +87.5% | +87.5% | -46.7% | +780.0% | -73.3% | +806.7% | >999% | +42.4% | >999% | +44.1% | +35.9% | +0.0% | -8.7% | +2.0% | +10.3% |